Nanovaccines have gathered significant attention for their potential to elicit tumor-specific
immunological responses. Despite notable progress in tumor immunotherapy, nanovaccines …

Tumor vaccines, an important part of immunotherapy, prevent cancer or kill existing tumor
cells by activating or restoring the body's own immune system. Currently, various …

Cancer vaccines show huge potential for cancer prevention and treatment. However, their
efficacy remains limited due to weak immunogenicity regarding inefficient stimulation of …

Personalized cancer vaccines based on tumor cell lysates offer promise for cancer
immunotherapy yet fail to elicit a robust therapeutic effect due to the weak immunogenicity of …

High‐performance theranostic systems are of paramount importance for achieving precise
image‐guided cancer immunotherapy. Here, a novel nanoplatform is presented that …

Cancer vaccines represent a promising form of immunotherapy employed in the treatment of
cancer. However, their efficiency in eliciting immune responses is limited, and satisfactory …

Cancer nanovaccines offer a promising strategy for fighting against tumors, however, the
engineering of cancer nanovaccines that can be easily fabricated with tanglesome cancer …

In situ vaccine (ISV) is a versatile and personalized local immunotherapeutic strategy.
However, the compromised viability and function of dendritic cells (DCs) in a tumor …

An obstacle in current tumor immunotherapies lies in the challenge of achieving sustained
and tumor-targeting T cell immunity, impeded by the limited antigen processing and cross …

Cancer nanovaccines represent a promising frontier in cancer immunotherapy, utilizing
nanotechnology to augment traditional vaccine efficacy. This review comprehensively …